EXAGEN INC. Total Assets
EXAGEN INC. (XGN) had Total Assets of $51.94 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-04
- 2026-06-30: Assets $51.94M.
- 2026-03-31: Assets $51.96M.
- 2025-12-31: Assets $58.02M.
- 2025-09-30: Assets $62.82M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $51.94M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $51.96M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $58.02M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $62.82M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $58.76M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $40.29M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $44.69M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $43.60M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $49.31M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $50.81M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $56.94M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $60.93M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $64.18M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $79.23M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $86.22M 10-K · filed 2024-03-18 | |
| 2022-09-30 | $101.60M 10-Q · filed 2022-11-21 | |
| 2022-06-30 | $106.85M 10-Q/A · filed 2022-11-21 | $107.72M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $122.04M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $123.44M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $127.77M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $133.32M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $137.52M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $78.38M 10-K · filed 2022-03-22 | |
| 2020-09-30 | $79.99M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $80.51M 10-Q · filed 2020-07-28 | |
| 2020-03-31 | $84.64M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $88.31M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $92.74M 10-Q · filed 2019-11-12 | |
| 2018-12-31 | $28.89M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |